Download presentation
Presentation is loading. Please wait.
Published byElisa Soler Modified over 5 years ago
1
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial Mani Kavuru, MDa, Julian Melamed, MDb, Gary Gross, MDc, Craig LaForce, MDd, Karen House, MSe, Barbara Prillaman, MSe, Leslie Baitinger, BSe, Anita Woodring, MSe, Tushar Shah, MDe Journal of Allergy and Clinical Immunology Volume 105, Issue 6, Pages (June 2000) DOI: /mai Copyright © 2000 Mosby, Inc. Terms and Conditions
2
Fig. 1 Mean change from baseline (before randomization of study drug) in serial FEV1 over 12 hours at day 1, week 1, and week 12. Journal of Allergy and Clinical Immunology , DOI: ( /mai ) Copyright © 2000 Mosby, Inc. Terms and Conditions
3
Fig. 2 Probability of remaining in the study (Kaplan-Meier survival curve). Journal of Allergy and Clinical Immunology , DOI: ( /mai ) Copyright © 2000 Mosby, Inc. Terms and Conditions
4
Fig. 3 Mean change from baseline in daily mean morning PEF.
Journal of Allergy and Clinical Immunology , DOI: ( /mai ) Copyright © 2000 Mosby, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.